nodes	percent_of_prediction	percent_of_DWPC	metapath
Dasatinib—BTK—Mitoxantrone—multiple sclerosis	0.26	0.541	CbGbCtD
Dasatinib—CYP1B1—Mitoxantrone—multiple sclerosis	0.0412	0.0857	CbGbCtD
Dasatinib—ABCG2—Cladribine—multiple sclerosis	0.0269	0.0559	CbGbCtD
Dasatinib—CYP1B1—Dexamethasone—multiple sclerosis	0.0214	0.0445	CbGbCtD
Dasatinib—ABCG2—Mitoxantrone—multiple sclerosis	0.0196	0.0408	CbGbCtD
Dasatinib—ABCG2—Dexamethasone—multiple sclerosis	0.0102	0.0211	CbGbCtD
Dasatinib—ABCB1—Methylprednisolone—multiple sclerosis	0.00969	0.0201	CbGbCtD
Dasatinib—CYP1A1—Dexamethasone—multiple sclerosis	0.00938	0.0195	CbGbCtD
Dasatinib—CYP3A4—Fingolimod—multiple sclerosis	0.00901	0.0187	CbGbCtD
Dasatinib—ABCG2—Methotrexate—multiple sclerosis	0.00817	0.017	CbGbCtD
Dasatinib—ABCB1—Mitoxantrone—multiple sclerosis	0.00707	0.0147	CbGbCtD
Dasatinib—ABCB1—Betamethasone—multiple sclerosis	0.0063	0.0131	CbGbCtD
Dasatinib—ABCB1—Prednisolone—multiple sclerosis	0.00621	0.0129	CbGbCtD
Dasatinib—ABCB1—Prednisone—multiple sclerosis	0.00587	0.0122	CbGbCtD
Dasatinib—CYP3A4—Methylprednisolone—multiple sclerosis	0.0058	0.0121	CbGbCtD
Dasatinib—CYP3A5—Dexamethasone—multiple sclerosis	0.00563	0.0117	CbGbCtD
Dasatinib—CYP3A4—Triamcinolone—multiple sclerosis	0.0044	0.00915	CbGbCtD
Dasatinib—CYP3A4—Mitoxantrone—multiple sclerosis	0.00423	0.00881	CbGbCtD
Dasatinib—CYP3A4—Betamethasone—multiple sclerosis	0.00377	0.00785	CbGbCtD
Dasatinib—CYP3A4—Prednisolone—multiple sclerosis	0.00372	0.00774	CbGbCtD
Dasatinib—ABCB1—Dexamethasone—multiple sclerosis	0.00366	0.00762	CbGbCtD
Dasatinib—CYP3A4—Prednisone—multiple sclerosis	0.00352	0.00731	CbGbCtD
Dasatinib—ABCB1—Methotrexate—multiple sclerosis	0.00294	0.00612	CbGbCtD
Dasatinib—CYP3A4—Dexamethasone—multiple sclerosis	0.0022	0.00457	CbGbCtD
Dasatinib—BTK—medulla oblongata—multiple sclerosis	0.000602	0.00516	CbGeAlD
Dasatinib—EPHA8—nervous system—multiple sclerosis	0.0006	0.00514	CbGeAlD
Dasatinib—SRMS—central nervous system—multiple sclerosis	0.00059	0.00505	CbGeAlD
Dasatinib—EPHB1—brain—multiple sclerosis	0.000583	0.00499	CbGeAlD
Dasatinib—EPHA8—central nervous system—multiple sclerosis	0.000578	0.00495	CbGeAlD
Dasatinib—STAT5B—nervous system—multiple sclerosis	0.000568	0.00486	CbGeAlD
Dasatinib—EPHA8—cerebellum—multiple sclerosis	0.000565	0.00483	CbGeAlD
Dasatinib—EPHA5—midbrain—multiple sclerosis	0.000565	0.00483	CbGeAlD
Dasatinib—FYN—brainstem—multiple sclerosis	0.000563	0.00482	CbGeAlD
Dasatinib—TESK1—medulla oblongata—multiple sclerosis	0.000558	0.00478	CbGeAlD
Dasatinib—EPHA5—spinal cord—multiple sclerosis	0.000551	0.00472	CbGeAlD
Dasatinib—STK36—medulla oblongata—multiple sclerosis	0.000549	0.0047	CbGeAlD
Dasatinib—STAT5B—central nervous system—multiple sclerosis	0.000546	0.00468	CbGeAlD
Dasatinib—BTK—spinal cord—multiple sclerosis	0.000537	0.0046	CbGeAlD
Dasatinib—STAT5B—cerebellum—multiple sclerosis	0.000534	0.00457	CbGeAlD
Dasatinib—EPHA3—nervous system—multiple sclerosis	0.000525	0.00449	CbGeAlD
Dasatinib—SIK2—brain—multiple sclerosis	0.000515	0.00441	CbGeAlD
Dasatinib—CSK—medulla oblongata—multiple sclerosis	0.000511	0.00438	CbGeAlD
Dasatinib—SIK3—nervous system—multiple sclerosis	0.00051	0.00437	CbGeAlD
Dasatinib—TESK1—midbrain—multiple sclerosis	0.00051	0.00437	CbGeAlD
Dasatinib—EPHA3—central nervous system—multiple sclerosis	0.000505	0.00432	CbGeAlD
Dasatinib—HCK—medulla oblongata—multiple sclerosis	0.000505	0.00432	CbGeAlD
Dasatinib—PKMYT1—brain—multiple sclerosis	0.000502	0.00429	CbGeAlD
Dasatinib—TESK1—spinal cord—multiple sclerosis	0.000498	0.00426	CbGeAlD
Dasatinib—SIK3—central nervous system—multiple sclerosis	0.000491	0.00421	CbGeAlD
Dasatinib—YES1—retina—multiple sclerosis	0.00049	0.0042	CbGeAlD
Dasatinib—EPHB3—spinal cord—multiple sclerosis	0.00049	0.00419	CbGeAlD
Dasatinib—SIK3—cerebellum—multiple sclerosis	0.00048	0.00411	CbGeAlD
Dasatinib—EPHB2—brain—multiple sclerosis	0.000479	0.0041	CbGeAlD
Dasatinib—RIPK2—medulla oblongata—multiple sclerosis	0.000475	0.00406	CbGeAlD
Dasatinib—ZAK—nervous system—multiple sclerosis	0.000474	0.00406	CbGeAlD
Dasatinib—LIMK2—spinal cord—multiple sclerosis	0.000474	0.00405	CbGeAlD
Dasatinib—SRC—retina—multiple sclerosis	0.000472	0.00404	CbGeAlD
Dasatinib—STK35—midbrain—multiple sclerosis	0.00047	0.00403	CbGeAlD
Dasatinib—SRMS—brain—multiple sclerosis	0.000468	0.00401	CbGeAlD
Dasatinib—CSK—midbrain—multiple sclerosis	0.000467	0.004	CbGeAlD
Dasatinib—EPHA5—nervous system—multiple sclerosis	0.000464	0.00397	CbGeAlD
Dasatinib—SIK1—medulla oblongata—multiple sclerosis	0.000463	0.00397	CbGeAlD
Dasatinib—LYN—nervous system—multiple sclerosis	0.000462	0.00395	CbGeAlD
Dasatinib—HCK—midbrain—multiple sclerosis	0.000461	0.00395	CbGeAlD
Dasatinib—EPHA4—medulla oblongata—multiple sclerosis	0.000459	0.00393	CbGeAlD
Dasatinib—EPHA8—brain—multiple sclerosis	0.000459	0.00393	CbGeAlD
Dasatinib—ZAK—central nervous system—multiple sclerosis	0.000457	0.00391	CbGeAlD
Dasatinib—CSK—spinal cord—multiple sclerosis	0.000456	0.0039	CbGeAlD
Dasatinib—MAP3K19—nervous system—multiple sclerosis	0.000455	0.00389	CbGeAlD
Dasatinib—BMPR1B—nervous system—multiple sclerosis	0.000455	0.00389	CbGeAlD
Dasatinib—HCK—spinal cord—multiple sclerosis	0.00045	0.00385	CbGeAlD
Dasatinib—MAP2K5—brainstem—multiple sclerosis	0.00045	0.00385	CbGeAlD
Dasatinib—EPHA5—central nervous system—multiple sclerosis	0.000447	0.00383	CbGeAlD
Dasatinib—ZAK—cerebellum—multiple sclerosis	0.000446	0.00382	CbGeAlD
Dasatinib—TNK2—nervous system—multiple sclerosis	0.000446	0.00382	CbGeAlD
Dasatinib—LYN—central nervous system—multiple sclerosis	0.000445	0.00381	CbGeAlD
Dasatinib—MAP3K19—central nervous system—multiple sclerosis	0.000438	0.00375	CbGeAlD
Dasatinib—BMPR1B—central nervous system—multiple sclerosis	0.000438	0.00375	CbGeAlD
Dasatinib—EPHA5—cerebellum—multiple sclerosis	0.000437	0.00374	CbGeAlD
Dasatinib—STAT5B—brain—multiple sclerosis	0.000434	0.00371	CbGeAlD
Dasatinib—RIPK2—midbrain—multiple sclerosis	0.000434	0.00371	CbGeAlD
Dasatinib—TNK2—central nervous system—multiple sclerosis	0.000429	0.00368	CbGeAlD
Dasatinib—BMPR1B—cerebellum—multiple sclerosis	0.000428	0.00366	CbGeAlD
Dasatinib—RIPK2—spinal cord—multiple sclerosis	0.000423	0.00362	CbGeAlD
Dasatinib—TNK2—cerebellum—multiple sclerosis	0.00042	0.00359	CbGeAlD
Dasatinib—TESK1—nervous system—multiple sclerosis	0.000419	0.00359	CbGeAlD
Dasatinib—ERBB3—midbrain—multiple sclerosis	0.000415	0.00355	CbGeAlD
Dasatinib—SIK1—spinal cord—multiple sclerosis	0.000413	0.00354	CbGeAlD
Dasatinib—EPHB3—nervous system—multiple sclerosis	0.000413	0.00353	CbGeAlD
Dasatinib—STK36—nervous system—multiple sclerosis	0.000413	0.00353	CbGeAlD
Dasatinib—ERBB3—spinal cord—multiple sclerosis	0.000405	0.00347	CbGeAlD
Dasatinib—TESK1—central nervous system—multiple sclerosis	0.000404	0.00346	CbGeAlD
Dasatinib—EPHB4—medulla oblongata—multiple sclerosis	0.000401	0.00343	CbGeAlD
Dasatinib—EPHA3—brain—multiple sclerosis	0.000401	0.00343	CbGeAlD
Dasatinib—LIMK2—nervous system—multiple sclerosis	0.000399	0.00342	CbGeAlD
Dasatinib—KIT—brainstem—multiple sclerosis	0.000399	0.00341	CbGeAlD
Dasatinib—JAK2—medulla oblongata—multiple sclerosis	0.000398	0.00341	CbGeAlD
Dasatinib—STK36—central nervous system—multiple sclerosis	0.000397	0.0034	CbGeAlD
Dasatinib—EPHB3—central nervous system—multiple sclerosis	0.000397	0.0034	CbGeAlD
Dasatinib—TESK1—cerebellum—multiple sclerosis	0.000395	0.00338	CbGeAlD
Dasatinib—FYN—medulla oblongata—multiple sclerosis	0.000393	0.00336	CbGeAlD
Dasatinib—SIK3—brain—multiple sclerosis	0.00039	0.00334	CbGeAlD
Dasatinib—STK36—cerebellum—multiple sclerosis	0.000388	0.00332	CbGeAlD
Dasatinib—EPHB3—cerebellum—multiple sclerosis	0.000388	0.00332	CbGeAlD
Dasatinib—STK35—nervous system—multiple sclerosis	0.000387	0.00331	CbGeAlD
Dasatinib—CSK—nervous system—multiple sclerosis	0.000384	0.00329	CbGeAlD
Dasatinib—LIMK2—central nervous system—multiple sclerosis	0.000384	0.00329	CbGeAlD
Dasatinib—MAP3K3—medulla oblongata—multiple sclerosis	0.000384	0.00329	CbGeAlD
Dasatinib—MAP4K5—medulla oblongata—multiple sclerosis	0.000384	0.00329	CbGeAlD
Dasatinib—HCK—nervous system—multiple sclerosis	0.000379	0.00325	CbGeAlD
Dasatinib—MAPK14—spinal cord—multiple sclerosis	0.000377	0.00323	CbGeAlD
Dasatinib—LIMK2—cerebellum—multiple sclerosis	0.000375	0.00321	CbGeAlD
Dasatinib—STK35—central nervous system—multiple sclerosis	0.000372	0.00319	CbGeAlD
Dasatinib—CSK—central nervous system—multiple sclerosis	0.00037	0.00317	CbGeAlD
Dasatinib—EPHB6—medulla oblongata—multiple sclerosis	0.000367	0.00314	CbGeAlD
Dasatinib—EPHB4—midbrain—multiple sclerosis	0.000367	0.00314	CbGeAlD
Dasatinib—HCK—central nervous system—multiple sclerosis	0.000365	0.00313	CbGeAlD
Dasatinib—STK35—cerebellum—multiple sclerosis	0.000364	0.00312	CbGeAlD
Dasatinib—ZAK—brain—multiple sclerosis	0.000363	0.0031	CbGeAlD
Dasatinib—CSK—cerebellum—multiple sclerosis	0.000362	0.00309	CbGeAlD
Dasatinib—FYN—midbrain—multiple sclerosis	0.000359	0.00307	CbGeAlD
Dasatinib—EPHB4—spinal cord—multiple sclerosis	0.000358	0.00306	CbGeAlD
Dasatinib—JAK2—spinal cord—multiple sclerosis	0.000355	0.00304	CbGeAlD
Dasatinib—EPHA5—brain—multiple sclerosis	0.000355	0.00304	CbGeAlD
Dasatinib—ABL2—cerebellum—multiple sclerosis	0.000355	0.00304	CbGeAlD
Dasatinib—YES1—medulla oblongata—multiple sclerosis	0.000354	0.00303	CbGeAlD
Dasatinib—LYN—brain—multiple sclerosis	0.000353	0.00302	CbGeAlD
Dasatinib—EPHB2—Diflorasone—Methylprednisolone—multiple sclerosis	0.000351	0.0989	CbGdCrCtD
Dasatinib—MAP4K5—midbrain—multiple sclerosis	0.000351	0.003	CbGeAlD
Dasatinib—MAP3K3—midbrain—multiple sclerosis	0.000351	0.003	CbGeAlD
Dasatinib—FYN—spinal cord—multiple sclerosis	0.00035	0.003	CbGeAlD
Dasatinib—SIK1—nervous system—multiple sclerosis	0.000348	0.00298	CbGeAlD
Dasatinib—MAP3K19—brain—multiple sclerosis	0.000348	0.00298	CbGeAlD
Dasatinib—BMPR1B—brain—multiple sclerosis	0.000348	0.00298	CbGeAlD
Dasatinib—ABL1—brainstem—multiple sclerosis	0.000347	0.00297	CbGeAlD
Dasatinib—BTK—brain—multiple sclerosis	0.000346	0.00296	CbGeAlD
Dasatinib—EPHB2—Diflorasone—Dexamethasone—multiple sclerosis	0.000345	0.0973	CbGdCrCtD
Dasatinib—EPHB2—Diflorasone—Betamethasone—multiple sclerosis	0.000345	0.0973	CbGdCrCtD
Dasatinib—EPHA4—nervous system—multiple sclerosis	0.000345	0.00295	CbGeAlD
Dasatinib—MAP4K5—spinal cord—multiple sclerosis	0.000342	0.00293	CbGeAlD
Dasatinib—MAP3K3—spinal cord—multiple sclerosis	0.000342	0.00293	CbGeAlD
Dasatinib—ERBB3—nervous system—multiple sclerosis	0.000341	0.00292	CbGeAlD
Dasatinib—TNK2—brain—multiple sclerosis	0.000341	0.00292	CbGeAlD
Dasatinib—MAP3K2—nervous system—multiple sclerosis	0.000338	0.00289	CbGeAlD
Dasatinib—EPHB2—Diflorasone—Triamcinolone—multiple sclerosis	0.000337	0.0951	CbGdCrCtD
Dasatinib—RIPK2—cerebellum—multiple sclerosis	0.000336	0.00287	CbGeAlD
Dasatinib—SIK1—central nervous system—multiple sclerosis	0.000335	0.00287	CbGeAlD
Dasatinib—EPHB6—midbrain—multiple sclerosis	0.000335	0.00287	CbGeAlD
Dasatinib—ABL1—retina—multiple sclerosis	0.000335	0.00287	CbGeAlD
Dasatinib—EPHA4—central nervous system—multiple sclerosis	0.000332	0.00284	CbGeAlD
Dasatinib—ERBB3—central nervous system—multiple sclerosis	0.000329	0.00281	CbGeAlD
Dasatinib—SIK1—cerebellum—multiple sclerosis	0.000328	0.00281	CbGeAlD
Dasatinib—EPHB6—spinal cord—multiple sclerosis	0.000327	0.0028	CbGeAlD
Dasatinib—MAP3K2—central nervous system—multiple sclerosis	0.000325	0.00279	CbGeAlD
Dasatinib—EPHA4—cerebellum—multiple sclerosis	0.000324	0.00278	CbGeAlD
Dasatinib—YES1—midbrain—multiple sclerosis	0.000324	0.00277	CbGeAlD
Dasatinib—ERBB3—cerebellum—multiple sclerosis	0.000321	0.00275	CbGeAlD
Dasatinib—TESK1—brain—multiple sclerosis	0.000321	0.00274	CbGeAlD
Dasatinib—EPHB2—Diflorasone—Prednisone—multiple sclerosis	0.00032	0.0903	CbGdCrCtD
Dasatinib—MAP3K2—cerebellum—multiple sclerosis	0.000318	0.00272	CbGeAlD
Dasatinib—MAPK14—nervous system—multiple sclerosis	0.000318	0.00272	CbGeAlD
Dasatinib—FGR—nervous system—multiple sclerosis	0.000317	0.00271	CbGeAlD
Dasatinib—YES1—spinal cord—multiple sclerosis	0.000316	0.00271	CbGeAlD
Dasatinib—STK36—brain—multiple sclerosis	0.000315	0.0027	CbGeAlD
Dasatinib—EPHB3—brain—multiple sclerosis	0.000315	0.0027	CbGeAlD
Dasatinib—MAP2K5—medulla oblongata—multiple sclerosis	0.000314	0.00268	CbGeAlD
Dasatinib—EPHB2—Diflorasone—Prednisolone—multiple sclerosis	0.000313	0.0881	CbGdCrCtD
Dasatinib—PDGFRA—spinal cord—multiple sclerosis	0.00031	0.00265	CbGeAlD
Dasatinib—CSF1R—medulla oblongata—multiple sclerosis	0.000306	0.00262	CbGeAlD
Dasatinib—MAPK14—central nervous system—multiple sclerosis	0.000306	0.00262	CbGeAlD
Dasatinib—FMO3—nervous system—multiple sclerosis	0.000306	0.00262	CbGeAlD
Dasatinib—LIMK2—brain—multiple sclerosis	0.000305	0.00261	CbGeAlD
Dasatinib—FGR—central nervous system—multiple sclerosis	0.000305	0.00261	CbGeAlD
Dasatinib—SRC—spinal cord—multiple sclerosis	0.000304	0.0026	CbGeAlD
Dasatinib—JAK2—nervous system—multiple sclerosis	0.000299	0.00256	CbGeAlD
Dasatinib—MAPK14—cerebellum—multiple sclerosis	0.000299	0.00256	CbGeAlD
Dasatinib—STK35—brain—multiple sclerosis	0.000296	0.00253	CbGeAlD
Dasatinib—EPHA2—nervous system—multiple sclerosis	0.000296	0.00253	CbGeAlD
Dasatinib—FYN—nervous system—multiple sclerosis	0.000295	0.00253	CbGeAlD
Dasatinib—FMO3—central nervous system—multiple sclerosis	0.000294	0.00252	CbGeAlD
Dasatinib—CSK—brain—multiple sclerosis	0.000294	0.00251	CbGeAlD
Dasatinib—HCK—brain—multiple sclerosis	0.00029	0.00248	CbGeAlD
Dasatinib—MAP4K5—nervous system—multiple sclerosis	0.000288	0.00247	CbGeAlD
Dasatinib—MAP3K3—nervous system—multiple sclerosis	0.000288	0.00247	CbGeAlD
Dasatinib—ABL2—brain—multiple sclerosis	0.000288	0.00247	CbGeAlD
Dasatinib—JAK2—central nervous system—multiple sclerosis	0.000288	0.00247	CbGeAlD
Dasatinib—MAP2K5—midbrain—multiple sclerosis	0.000287	0.00245	CbGeAlD
Dasatinib—EPHA2—central nervous system—multiple sclerosis	0.000285	0.00244	CbGeAlD
Dasatinib—FYN—central nervous system—multiple sclerosis	0.000284	0.00243	CbGeAlD
Dasatinib—EPHB4—cerebellum—multiple sclerosis	0.000284	0.00243	CbGeAlD
Dasatinib—JAK2—cerebellum—multiple sclerosis	0.000282	0.00241	CbGeAlD
Dasatinib—CSF1R—midbrain—multiple sclerosis	0.00028	0.00239	CbGeAlD
Dasatinib—MAP2K5—spinal cord—multiple sclerosis	0.00028	0.00239	CbGeAlD
Dasatinib—KIT—medulla oblongata—multiple sclerosis	0.000278	0.00238	CbGeAlD
Dasatinib—FYN—cerebellum—multiple sclerosis	0.000278	0.00238	CbGeAlD
Dasatinib—MAP4K5—central nervous system—multiple sclerosis	0.000278	0.00238	CbGeAlD
Dasatinib—MAP3K3—central nervous system—multiple sclerosis	0.000278	0.00238	CbGeAlD
Dasatinib—EPHB6—nervous system—multiple sclerosis	0.000276	0.00236	CbGeAlD
Dasatinib—CSF1R—spinal cord—multiple sclerosis	0.000273	0.00234	CbGeAlD
Dasatinib—RIPK2—brain—multiple sclerosis	0.000273	0.00233	CbGeAlD
Dasatinib—PDGFRB—medulla oblongata—multiple sclerosis	0.000271	0.00232	CbGeAlD
Dasatinib—MAP3K3—cerebellum—multiple sclerosis	0.000271	0.00232	CbGeAlD
Dasatinib—MAP4K5—cerebellum—multiple sclerosis	0.000271	0.00232	CbGeAlD
Dasatinib—YES1—nervous system—multiple sclerosis	0.000266	0.00228	CbGeAlD
Dasatinib—SIK1—brain—multiple sclerosis	0.000266	0.00228	CbGeAlD
Dasatinib—EPHB6—central nervous system—multiple sclerosis	0.000265	0.00227	CbGeAlD
Dasatinib—EPHA4—brain—multiple sclerosis	0.000264	0.00226	CbGeAlD
Dasatinib—PDGFRA—nervous system—multiple sclerosis	0.000261	0.00224	CbGeAlD
Dasatinib—ERBB3—brain—multiple sclerosis	0.000261	0.00223	CbGeAlD
Dasatinib—EPHB6—cerebellum—multiple sclerosis	0.000259	0.00222	CbGeAlD
Dasatinib—MAP3K2—brain—multiple sclerosis	0.000258	0.00221	CbGeAlD
Dasatinib—YES1—central nervous system—multiple sclerosis	0.000256	0.00219	CbGeAlD
Dasatinib—SRC—nervous system—multiple sclerosis	0.000256	0.00219	CbGeAlD
Dasatinib—KIT—midbrain—multiple sclerosis	0.000254	0.00217	CbGeAlD
Dasatinib—PDGFRA—central nervous system—multiple sclerosis	0.000252	0.00215	CbGeAlD
Dasatinib—YES1—cerebellum—multiple sclerosis	0.000251	0.00215	CbGeAlD
Dasatinib—PDGFRB—midbrain—multiple sclerosis	0.000248	0.00212	CbGeAlD
Dasatinib—KIT—spinal cord—multiple sclerosis	0.000248	0.00212	CbGeAlD
Dasatinib—SRC—central nervous system—multiple sclerosis	0.000247	0.00211	CbGeAlD
Dasatinib—PDGFRA—cerebellum—multiple sclerosis	0.000246	0.0021	CbGeAlD
Dasatinib—MAPK14—brain—multiple sclerosis	0.000243	0.00208	CbGeAlD
Dasatinib—PDGFRB—spinal cord—multiple sclerosis	0.000242	0.00207	CbGeAlD
Dasatinib—ABL1—medulla oblongata—multiple sclerosis	0.000242	0.00207	CbGeAlD
Dasatinib—FGR—brain—multiple sclerosis	0.000242	0.00207	CbGeAlD
Dasatinib—SRC—cerebellum—multiple sclerosis	0.000241	0.00206	CbGeAlD
Dasatinib—MAP2K5—nervous system—multiple sclerosis	0.000236	0.00202	CbGeAlD
Dasatinib—FMO3—brain—multiple sclerosis	0.000234	0.002	CbGeAlD
Dasatinib—EPHB4—brain—multiple sclerosis	0.00023	0.00197	CbGeAlD
Dasatinib—CSF1R—nervous system—multiple sclerosis	0.00023	0.00197	CbGeAlD
Dasatinib—JAK2—brain—multiple sclerosis	0.000229	0.00196	CbGeAlD
Dasatinib—MAP2K5—central nervous system—multiple sclerosis	0.000227	0.00194	CbGeAlD
Dasatinib—EPHA2—brain—multiple sclerosis	0.000226	0.00193	CbGeAlD
Dasatinib—FYN—brain—multiple sclerosis	0.000226	0.00193	CbGeAlD
Dasatinib—MAP2K5—cerebellum—multiple sclerosis	0.000222	0.0019	CbGeAlD
Dasatinib—CSF1R—central nervous system—multiple sclerosis	0.000221	0.0019	CbGeAlD
Dasatinib—ABL1—midbrain—multiple sclerosis	0.000221	0.00189	CbGeAlD
Dasatinib—MAP3K3—brain—multiple sclerosis	0.00022	0.00189	CbGeAlD
Dasatinib—MAP4K5—brain—multiple sclerosis	0.00022	0.00189	CbGeAlD
Dasatinib—CSF1R—cerebellum—multiple sclerosis	0.000216	0.00185	CbGeAlD
Dasatinib—ABL1—spinal cord—multiple sclerosis	0.000216	0.00185	CbGeAlD
Dasatinib—EPHB6—brain—multiple sclerosis	0.000211	0.0018	CbGeAlD
Dasatinib—KIT—nervous system—multiple sclerosis	0.000209	0.00179	CbGeAlD
Dasatinib—PDGFRB—nervous system—multiple sclerosis	0.000204	0.00175	CbGeAlD
Dasatinib—YES1—brain—multiple sclerosis	0.000204	0.00174	CbGeAlD
Dasatinib—KIT—central nervous system—multiple sclerosis	0.000201	0.00172	CbGeAlD
Dasatinib—PDGFRA—brain—multiple sclerosis	0.0002	0.00171	CbGeAlD
Dasatinib—KIT—cerebellum—multiple sclerosis	0.000197	0.00168	CbGeAlD
Dasatinib—PDGFRB—central nervous system—multiple sclerosis	0.000196	0.00168	CbGeAlD
Dasatinib—SRC—brain—multiple sclerosis	0.000196	0.00168	CbGeAlD
Dasatinib—PDGFRB—cerebellum—multiple sclerosis	0.000192	0.00164	CbGeAlD
Dasatinib—ABL1—nervous system—multiple sclerosis	0.000182	0.00156	CbGeAlD
Dasatinib—PKMYT1—Danazol—Prednisone—multiple sclerosis	0.000182	0.0512	CbGdCrCtD
Dasatinib—MAP2K5—brain—multiple sclerosis	0.00018	0.00154	CbGeAlD
Dasatinib—CSF1R—brain—multiple sclerosis	0.000176	0.0015	CbGeAlD
Dasatinib—ABL1—central nervous system—multiple sclerosis	0.000175	0.0015	CbGeAlD
Dasatinib—ABL1—cerebellum—multiple sclerosis	0.000171	0.00146	CbGeAlD
Dasatinib—KIT—brain—multiple sclerosis	0.00016	0.00137	CbGeAlD
Dasatinib—PDGFRB—brain—multiple sclerosis	0.000156	0.00133	CbGeAlD
Dasatinib—CYP1B1—nervous system—multiple sclerosis	0.000154	0.00132	CbGeAlD
Dasatinib—ABCG2—medulla oblongata—multiple sclerosis	0.000153	0.00131	CbGeAlD
Dasatinib—CYP1B1—central nervous system—multiple sclerosis	0.000148	0.00127	CbGeAlD
Dasatinib—CYP1B1—cerebellum—multiple sclerosis	0.000145	0.00124	CbGeAlD
Dasatinib—TESK1—Betamethasone—Methylprednisolone—multiple sclerosis	0.000143	0.0402	CbGdCrCtD
Dasatinib—TESK1—Dexamethasone—Methylprednisolone—multiple sclerosis	0.000143	0.0402	CbGdCrCtD
Dasatinib—TESK1—Betamethasone—Dexamethasone—multiple sclerosis	0.00014	0.0396	CbGdCrCtD
Dasatinib—TESK1—Dexamethasone—Betamethasone—multiple sclerosis	0.00014	0.0396	CbGdCrCtD
Dasatinib—ABCG2—midbrain—multiple sclerosis	0.000139	0.00119	CbGeAlD
Dasatinib—ABL1—brain—multiple sclerosis	0.000139	0.00119	CbGeAlD
Dasatinib—TESK1—Betamethasone—Triamcinolone—multiple sclerosis	0.000137	0.0387	CbGdCrCtD
Dasatinib—TESK1—Dexamethasone—Triamcinolone—multiple sclerosis	0.000137	0.0387	CbGdCrCtD
Dasatinib—ABCG2—spinal cord—multiple sclerosis	0.000136	0.00116	CbGeAlD
Dasatinib—TESK1—Dexamethasone—Prednisone—multiple sclerosis	0.00013	0.0367	CbGdCrCtD
Dasatinib—TESK1—Betamethasone—Prednisone—multiple sclerosis	0.00013	0.0367	CbGdCrCtD
Dasatinib—TESK1—Betamethasone—Prednisolone—multiple sclerosis	0.000127	0.0358	CbGdCrCtD
Dasatinib—TESK1—Dexamethasone—Prednisolone—multiple sclerosis	0.000127	0.0358	CbGdCrCtD
Dasatinib—CYP1B1—brain—multiple sclerosis	0.000118	0.00101	CbGeAlD
Dasatinib—CYP1A1—nervous system—multiple sclerosis	0.000109	0.000932	CbGeAlD
Dasatinib—ABCG2—cerebellum—multiple sclerosis	0.000108	0.000924	CbGeAlD
Dasatinib—CYP1A1—central nervous system—multiple sclerosis	0.000105	0.000897	CbGeAlD
Dasatinib—ABCB1—retina—multiple sclerosis	0.000104	0.000891	CbGeAlD
Dasatinib—ABCG2—brain—multiple sclerosis	8.76e-05	0.00075	CbGeAlD
Dasatinib—CYP1A1—brain—multiple sclerosis	8.32e-05	0.000712	CbGeAlD
Dasatinib—Infection—Methylprednisolone—multiple sclerosis	8.3e-05	0.000472	CcSEcCtD
Dasatinib—Haematuria—Methotrexate—multiple sclerosis	8.27e-05	0.00047	CcSEcCtD
Dasatinib—Shock—Triamcinolone—multiple sclerosis	8.24e-05	0.000468	CcSEcCtD
Dasatinib—Insomnia—Prednisolone—multiple sclerosis	8.24e-05	0.000468	CcSEcCtD
Dasatinib—Alopecia—Prednisone—multiple sclerosis	8.23e-05	0.000468	CcSEcCtD
Dasatinib—Shock—Methylprednisolone—multiple sclerosis	8.22e-05	0.000467	CcSEcCtD
Dasatinib—Hepatobiliary disease—Methotrexate—multiple sclerosis	8.2e-05	0.000466	CcSEcCtD
Dasatinib—Nervous system disorder—Methylprednisolone—multiple sclerosis	8.2e-05	0.000466	CcSEcCtD
Dasatinib—Loss of consciousness—Dexamethasone—multiple sclerosis	8.18e-05	0.000465	CcSEcCtD
Dasatinib—Loss of consciousness—Betamethasone—multiple sclerosis	8.18e-05	0.000465	CcSEcCtD
Dasatinib—Epistaxis—Methotrexate—multiple sclerosis	8.18e-05	0.000465	CcSEcCtD
Dasatinib—Hypersensitivity—Mitoxantrone—multiple sclerosis	8.18e-05	0.000465	CcSEcCtD
Dasatinib—Tachycardia—Triamcinolone—multiple sclerosis	8.17e-05	0.000465	CcSEcCtD
Dasatinib—Mental disorder—Prednisone—multiple sclerosis	8.16e-05	0.000464	CcSEcCtD
Dasatinib—Nausea—Azathioprine—multiple sclerosis	8.16e-05	0.000464	CcSEcCtD
Dasatinib—Tachycardia—Methylprednisolone—multiple sclerosis	8.16e-05	0.000464	CcSEcCtD
Dasatinib—Skin disorder—Methylprednisolone—multiple sclerosis	8.12e-05	0.000461	CcSEcCtD
Dasatinib—Malnutrition—Prednisone—multiple sclerosis	8.11e-05	0.000461	CcSEcCtD
Dasatinib—Erythema—Prednisone—multiple sclerosis	8.11e-05	0.000461	CcSEcCtD
Dasatinib—Hyperhidrosis—Triamcinolone—multiple sclerosis	8.1e-05	0.00046	CcSEcCtD
Dasatinib—Hyperhidrosis—Methylprednisolone—multiple sclerosis	8.08e-05	0.000459	CcSEcCtD
Dasatinib—Convulsion—Betamethasone—multiple sclerosis	8.07e-05	0.000459	CcSEcCtD
Dasatinib—Convulsion—Dexamethasone—multiple sclerosis	8.07e-05	0.000459	CcSEcCtD
Dasatinib—Hypertension—Dexamethasone—multiple sclerosis	8.04e-05	0.000457	CcSEcCtD
Dasatinib—Hypertension—Betamethasone—multiple sclerosis	8.04e-05	0.000457	CcSEcCtD
Dasatinib—CYP3A4—nervous system—multiple sclerosis	7.99e-05	0.000684	CbGeAlD
Dasatinib—Asthenia—Mitoxantrone—multiple sclerosis	7.97e-05	0.000453	CcSEcCtD
Dasatinib—Myalgia—Betamethasone—multiple sclerosis	7.93e-05	0.000451	CcSEcCtD
Dasatinib—Myalgia—Dexamethasone—multiple sclerosis	7.93e-05	0.000451	CcSEcCtD
Dasatinib—Anxiety—Betamethasone—multiple sclerosis	7.9e-05	0.000449	CcSEcCtD
Dasatinib—Anxiety—Dexamethasone—multiple sclerosis	7.9e-05	0.000449	CcSEcCtD
Dasatinib—Discomfort—Dexamethasone—multiple sclerosis	7.83e-05	0.000445	CcSEcCtD
Dasatinib—Discomfort—Betamethasone—multiple sclerosis	7.83e-05	0.000445	CcSEcCtD
Dasatinib—Haemoglobin—Methotrexate—multiple sclerosis	7.82e-05	0.000445	CcSEcCtD
Dasatinib—Hypotension—Methylprednisolone—multiple sclerosis	7.81e-05	0.000444	CcSEcCtD
Dasatinib—Pain—Prednisolone—multiple sclerosis	7.79e-05	0.000443	CcSEcCtD
Dasatinib—Hepatitis—Methotrexate—multiple sclerosis	7.79e-05	0.000442	CcSEcCtD
Dasatinib—Haemorrhage—Methotrexate—multiple sclerosis	7.79e-05	0.000442	CcSEcCtD
Dasatinib—CYP3A4—central nervous system—multiple sclerosis	7.69e-05	0.000658	CbGeAlD
Dasatinib—Urinary tract disorder—Methotrexate—multiple sclerosis	7.69e-05	0.000437	CcSEcCtD
Dasatinib—Vision blurred—Prednisone—multiple sclerosis	7.64e-05	0.000434	CcSEcCtD
Dasatinib—Urethral disorder—Methotrexate—multiple sclerosis	7.63e-05	0.000434	CcSEcCtD
Dasatinib—Musculoskeletal discomfort—Triamcinolone—multiple sclerosis	7.63e-05	0.000434	CcSEcCtD
Dasatinib—Musculoskeletal discomfort—Methylprednisolone—multiple sclerosis	7.61e-05	0.000433	CcSEcCtD
Dasatinib—Oedema—Dexamethasone—multiple sclerosis	7.6e-05	0.000432	CcSEcCtD
Dasatinib—Oedema—Betamethasone—multiple sclerosis	7.6e-05	0.000432	CcSEcCtD
Dasatinib—Diarrhoea—Mitoxantrone—multiple sclerosis	7.6e-05	0.000432	CcSEcCtD
Dasatinib—Insomnia—Triamcinolone—multiple sclerosis	7.58e-05	0.000431	CcSEcCtD
Dasatinib—Insomnia—Methylprednisolone—multiple sclerosis	7.56e-05	0.00043	CcSEcCtD
Dasatinib—Infection—Betamethasone—multiple sclerosis	7.55e-05	0.000429	CcSEcCtD
Dasatinib—Infection—Dexamethasone—multiple sclerosis	7.55e-05	0.000429	CcSEcCtD
Dasatinib—ABCB1—medulla oblongata—multiple sclerosis	7.52e-05	0.000644	CbGeAlD
Dasatinib—Ill-defined disorder—Prednisone—multiple sclerosis	7.52e-05	0.000428	CcSEcCtD
Dasatinib—Feeling abnormal—Prednisolone—multiple sclerosis	7.51e-05	0.000427	CcSEcCtD
Dasatinib—Visual impairment—Methotrexate—multiple sclerosis	7.5e-05	0.000426	CcSEcCtD
Dasatinib—Anaemia—Prednisone—multiple sclerosis	7.5e-05	0.000426	CcSEcCtD
Dasatinib—Shock—Betamethasone—multiple sclerosis	7.48e-05	0.000425	CcSEcCtD
Dasatinib—Shock—Dexamethasone—multiple sclerosis	7.48e-05	0.000425	CcSEcCtD
Dasatinib—Dyspnoea—Triamcinolone—multiple sclerosis	7.47e-05	0.000424	CcSEcCtD
Dasatinib—Nervous system disorder—Dexamethasone—multiple sclerosis	7.45e-05	0.000424	CcSEcCtD
Dasatinib—Nervous system disorder—Betamethasone—multiple sclerosis	7.45e-05	0.000424	CcSEcCtD
Dasatinib—Thrombocytopenia—Dexamethasone—multiple sclerosis	7.44e-05	0.000423	CcSEcCtD
Dasatinib—Thrombocytopenia—Betamethasone—multiple sclerosis	7.44e-05	0.000423	CcSEcCtD
Dasatinib—Tachycardia—Dexamethasone—multiple sclerosis	7.42e-05	0.000422	CcSEcCtD
Dasatinib—Tachycardia—Betamethasone—multiple sclerosis	7.42e-05	0.000422	CcSEcCtD
Dasatinib—Dyspepsia—Triamcinolone—multiple sclerosis	7.37e-05	0.000419	CcSEcCtD
Dasatinib—Erythema multiforme—Methotrexate—multiple sclerosis	7.36e-05	0.000418	CcSEcCtD
Dasatinib—Dyspepsia—Methylprednisolone—multiple sclerosis	7.36e-05	0.000418	CcSEcCtD
Dasatinib—Hyperhidrosis—Betamethasone—multiple sclerosis	7.35e-05	0.000418	CcSEcCtD
Dasatinib—Hyperhidrosis—Dexamethasone—multiple sclerosis	7.35e-05	0.000418	CcSEcCtD
Dasatinib—Malaise—Prednisone—multiple sclerosis	7.31e-05	0.000416	CcSEcCtD
Dasatinib—Vertigo—Prednisone—multiple sclerosis	7.29e-05	0.000414	CcSEcCtD
Dasatinib—Eye disorder—Methotrexate—multiple sclerosis	7.28e-05	0.000413	CcSEcCtD
Dasatinib—Syncope—Prednisone—multiple sclerosis	7.27e-05	0.000413	CcSEcCtD
Dasatinib—Tinnitus—Methotrexate—multiple sclerosis	7.26e-05	0.000413	CcSEcCtD
Dasatinib—Anorexia—Dexamethasone—multiple sclerosis	7.24e-05	0.000412	CcSEcCtD
Dasatinib—Anorexia—Betamethasone—multiple sclerosis	7.24e-05	0.000412	CcSEcCtD
Dasatinib—Urticaria—Prednisolone—multiple sclerosis	7.24e-05	0.000411	CcSEcCtD
Dasatinib—Cardiac disorder—Methotrexate—multiple sclerosis	7.23e-05	0.000411	CcSEcCtD
Dasatinib—Fatigue—Triamcinolone—multiple sclerosis	7.22e-05	0.00041	CcSEcCtD
Dasatinib—Fatigue—Methylprednisolone—multiple sclerosis	7.21e-05	0.000409	CcSEcCtD
Dasatinib—Pain—Triamcinolone—multiple sclerosis	7.16e-05	0.000407	CcSEcCtD
Dasatinib—Loss of consciousness—Prednisone—multiple sclerosis	7.13e-05	0.000405	CcSEcCtD
Dasatinib—Hypotension—Betamethasone—multiple sclerosis	7.1e-05	0.000404	CcSEcCtD
Dasatinib—Hypotension—Dexamethasone—multiple sclerosis	7.1e-05	0.000404	CcSEcCtD
Dasatinib—Angiopathy—Methotrexate—multiple sclerosis	7.06e-05	0.000401	CcSEcCtD
Dasatinib—Vomiting—Mitoxantrone—multiple sclerosis	7.06e-05	0.000401	CcSEcCtD
Dasatinib—Immune system disorder—Methotrexate—multiple sclerosis	7.03e-05	0.0004	CcSEcCtD
Dasatinib—Convulsion—Prednisone—multiple sclerosis	7.03e-05	0.000399	CcSEcCtD
Dasatinib—Mediastinal disorder—Methotrexate—multiple sclerosis	7.02e-05	0.000399	CcSEcCtD
Dasatinib—Hypertension—Prednisone—multiple sclerosis	7e-05	0.000398	CcSEcCtD
Dasatinib—Rash—Mitoxantrone—multiple sclerosis	7e-05	0.000398	CcSEcCtD
Dasatinib—Dermatitis—Mitoxantrone—multiple sclerosis	6.99e-05	0.000397	CcSEcCtD
Dasatinib—Chills—Methotrexate—multiple sclerosis	6.99e-05	0.000397	CcSEcCtD
Dasatinib—Headache—Mitoxantrone—multiple sclerosis	6.95e-05	0.000395	CcSEcCtD
Dasatinib—Musculoskeletal discomfort—Dexamethasone—multiple sclerosis	6.92e-05	0.000393	CcSEcCtD
Dasatinib—Musculoskeletal discomfort—Betamethasone—multiple sclerosis	6.92e-05	0.000393	CcSEcCtD
Dasatinib—Arthralgia—Prednisone—multiple sclerosis	6.9e-05	0.000392	CcSEcCtD
Dasatinib—Myalgia—Prednisone—multiple sclerosis	6.9e-05	0.000392	CcSEcCtD
Dasatinib—Feeling abnormal—Triamcinolone—multiple sclerosis	6.9e-05	0.000392	CcSEcCtD
Dasatinib—Feeling abnormal—Methylprednisolone—multiple sclerosis	6.89e-05	0.000391	CcSEcCtD
Dasatinib—Anxiety—Prednisone—multiple sclerosis	6.88e-05	0.000391	CcSEcCtD
Dasatinib—Alopecia—Methotrexate—multiple sclerosis	6.88e-05	0.000391	CcSEcCtD
Dasatinib—ABCB1—midbrain—multiple sclerosis	6.88e-05	0.000589	CbGeAlD
Dasatinib—Insomnia—Betamethasone—multiple sclerosis	6.87e-05	0.000391	CcSEcCtD
Dasatinib—Insomnia—Dexamethasone—multiple sclerosis	6.87e-05	0.000391	CcSEcCtD
Dasatinib—Unspecified disorder of skin and subcutaneous tissue—Prednisone—multiple sclerosis	6.86e-05	0.00039	CcSEcCtD
Dasatinib—Gastrointestinal pain—Methylprednisolone—multiple sclerosis	6.83e-05	0.000388	CcSEcCtD
Dasatinib—Discomfort—Prednisone—multiple sclerosis	6.82e-05	0.000388	CcSEcCtD
Dasatinib—Mental disorder—Methotrexate—multiple sclerosis	6.82e-05	0.000388	CcSEcCtD
Dasatinib—Erythema—Methotrexate—multiple sclerosis	6.78e-05	0.000385	CcSEcCtD
Dasatinib—Malnutrition—Methotrexate—multiple sclerosis	6.78e-05	0.000385	CcSEcCtD
Dasatinib—Hypersensitivity—Prednisolone—multiple sclerosis	6.71e-05	0.000381	CcSEcCtD
Dasatinib—ABCB1—spinal cord—multiple sclerosis	6.71e-05	0.000574	CbGeAlD
Dasatinib—Dyspepsia—Betamethasone—multiple sclerosis	6.69e-05	0.00038	CcSEcCtD
Dasatinib—Dyspepsia—Dexamethasone—multiple sclerosis	6.69e-05	0.00038	CcSEcCtD
Dasatinib—Urticaria—Triamcinolone—multiple sclerosis	6.65e-05	0.000378	CcSEcCtD
Dasatinib—Urticaria—Methylprednisolone—multiple sclerosis	6.64e-05	0.000377	CcSEcCtD
Dasatinib—Dysgeusia—Methotrexate—multiple sclerosis	6.64e-05	0.000377	CcSEcCtD
Dasatinib—Body temperature increased—Triamcinolone—multiple sclerosis	6.62e-05	0.000376	CcSEcCtD
Dasatinib—Oedema—Prednisone—multiple sclerosis	6.62e-05	0.000376	CcSEcCtD
Dasatinib—Abdominal pain—Methylprednisolone—multiple sclerosis	6.61e-05	0.000375	CcSEcCtD
Dasatinib—Decreased appetite—Dexamethasone—multiple sclerosis	6.61e-05	0.000375	CcSEcCtD
Dasatinib—Decreased appetite—Betamethasone—multiple sclerosis	6.61e-05	0.000375	CcSEcCtD
Dasatinib—Nausea—Mitoxantrone—multiple sclerosis	6.59e-05	0.000375	CcSEcCtD
Dasatinib—Infection—Prednisone—multiple sclerosis	6.58e-05	0.000374	CcSEcCtD
Dasatinib—Gastrointestinal disorder—Dexamethasone—multiple sclerosis	6.56e-05	0.000373	CcSEcCtD
Dasatinib—Gastrointestinal disorder—Betamethasone—multiple sclerosis	6.56e-05	0.000373	CcSEcCtD
Dasatinib—Fatigue—Dexamethasone—multiple sclerosis	6.55e-05	0.000372	CcSEcCtD
Dasatinib—Fatigue—Betamethasone—multiple sclerosis	6.55e-05	0.000372	CcSEcCtD
Dasatinib—Shock—Prednisone—multiple sclerosis	6.51e-05	0.00037	CcSEcCtD
Dasatinib—Pain—Dexamethasone—multiple sclerosis	6.5e-05	0.000369	CcSEcCtD
Dasatinib—Pain—Betamethasone—multiple sclerosis	6.5e-05	0.000369	CcSEcCtD
Dasatinib—Nervous system disorder—Prednisone—multiple sclerosis	6.49e-05	0.000369	CcSEcCtD
Dasatinib—Tachycardia—Prednisone—multiple sclerosis	6.46e-05	0.000367	CcSEcCtD
Dasatinib—Skin disorder—Prednisone—multiple sclerosis	6.43e-05	0.000365	CcSEcCtD
Dasatinib—Hyperhidrosis—Prednisone—multiple sclerosis	6.4e-05	0.000364	CcSEcCtD
Dasatinib—Vision blurred—Methotrexate—multiple sclerosis	6.39e-05	0.000363	CcSEcCtD
Dasatinib—Anorexia—Prednisone—multiple sclerosis	6.31e-05	0.000359	CcSEcCtD
Dasatinib—Ill-defined disorder—Methotrexate—multiple sclerosis	6.29e-05	0.000357	CcSEcCtD
Dasatinib—Anaemia—Methotrexate—multiple sclerosis	6.26e-05	0.000356	CcSEcCtD
Dasatinib—Feeling abnormal—Betamethasone—multiple sclerosis	6.26e-05	0.000356	CcSEcCtD
Dasatinib—Feeling abnormal—Dexamethasone—multiple sclerosis	6.26e-05	0.000356	CcSEcCtD
Dasatinib—Gastrointestinal pain—Betamethasone—multiple sclerosis	6.21e-05	0.000353	CcSEcCtD
Dasatinib—Gastrointestinal pain—Dexamethasone—multiple sclerosis	6.21e-05	0.000353	CcSEcCtD
Dasatinib—Hypersensitivity—Triamcinolone—multiple sclerosis	6.17e-05	0.000351	CcSEcCtD
Dasatinib—Hypersensitivity—Methylprednisolone—multiple sclerosis	6.16e-05	0.00035	CcSEcCtD
Dasatinib—Malaise—Methotrexate—multiple sclerosis	6.11e-05	0.000347	CcSEcCtD
Dasatinib—Vertigo—Methotrexate—multiple sclerosis	6.09e-05	0.000346	CcSEcCtD
Dasatinib—Urticaria—Betamethasone—multiple sclerosis	6.04e-05	0.000343	CcSEcCtD
Dasatinib—Urticaria—Dexamethasone—multiple sclerosis	6.04e-05	0.000343	CcSEcCtD
Dasatinib—Musculoskeletal discomfort—Prednisone—multiple sclerosis	6.03e-05	0.000343	CcSEcCtD
Dasatinib—Dizziness—Prednisolone—multiple sclerosis	6.02e-05	0.000342	CcSEcCtD
Dasatinib—Asthenia—Triamcinolone—multiple sclerosis	6.01e-05	0.000342	CcSEcCtD
Dasatinib—Abdominal pain—Betamethasone—multiple sclerosis	6.01e-05	0.000341	CcSEcCtD
Dasatinib—Body temperature increased—Betamethasone—multiple sclerosis	6.01e-05	0.000341	CcSEcCtD
Dasatinib—Body temperature increased—Dexamethasone—multiple sclerosis	6.01e-05	0.000341	CcSEcCtD
Dasatinib—Abdominal pain—Dexamethasone—multiple sclerosis	6.01e-05	0.000341	CcSEcCtD
Dasatinib—Asthenia—Methylprednisolone—multiple sclerosis	6e-05	0.000341	CcSEcCtD
Dasatinib—Insomnia—Prednisone—multiple sclerosis	5.99e-05	0.00034	CcSEcCtD
Dasatinib—Pruritus—Triamcinolone—multiple sclerosis	5.93e-05	0.000337	CcSEcCtD
Dasatinib—Cough—Methotrexate—multiple sclerosis	5.91e-05	0.000336	CcSEcCtD
Dasatinib—Pruritus—Methylprednisolone—multiple sclerosis	5.91e-05	0.000336	CcSEcCtD
Dasatinib—Convulsion—Methotrexate—multiple sclerosis	5.87e-05	0.000334	CcSEcCtD
Dasatinib—Dyspepsia—Prednisone—multiple sclerosis	5.83e-05	0.000331	CcSEcCtD
Dasatinib—Arthralgia—Methotrexate—multiple sclerosis	5.77e-05	0.000328	CcSEcCtD
Dasatinib—Chest pain—Methotrexate—multiple sclerosis	5.77e-05	0.000328	CcSEcCtD
Dasatinib—Myalgia—Methotrexate—multiple sclerosis	5.77e-05	0.000328	CcSEcCtD
Dasatinib—Decreased appetite—Prednisone—multiple sclerosis	5.75e-05	0.000327	CcSEcCtD
Dasatinib—Rash—Prednisolone—multiple sclerosis	5.74e-05	0.000326	CcSEcCtD
Dasatinib—Dermatitis—Prednisolone—multiple sclerosis	5.74e-05	0.000326	CcSEcCtD
Dasatinib—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—multiple sclerosis	5.73e-05	0.000326	CcSEcCtD
Dasatinib—Diarrhoea—Methylprednisolone—multiple sclerosis	5.72e-05	0.000325	CcSEcCtD
Dasatinib—Fatigue—Prednisone—multiple sclerosis	5.71e-05	0.000324	CcSEcCtD
Dasatinib—Headache—Prednisolone—multiple sclerosis	5.71e-05	0.000324	CcSEcCtD
Dasatinib—Discomfort—Methotrexate—multiple sclerosis	5.7e-05	0.000324	CcSEcCtD
Dasatinib—Constipation—Prednisone—multiple sclerosis	5.66e-05	0.000322	CcSEcCtD
Dasatinib—ABCB1—nervous system—multiple sclerosis	5.65e-05	0.000484	CbGeAlD
Dasatinib—Confusional state—Methotrexate—multiple sclerosis	5.58e-05	0.000317	CcSEcCtD
Dasatinib—Dizziness—Triamcinolone—multiple sclerosis	5.54e-05	0.000315	CcSEcCtD
Dasatinib—Dizziness—Methylprednisolone—multiple sclerosis	5.53e-05	0.000314	CcSEcCtD
Dasatinib—Infection—Methotrexate—multiple sclerosis	5.5e-05	0.000312	CcSEcCtD
Dasatinib—Feeling abnormal—Prednisone—multiple sclerosis	5.45e-05	0.00031	CcSEcCtD
Dasatinib—Asthenia—Betamethasone—multiple sclerosis	5.45e-05	0.00031	CcSEcCtD
Dasatinib—Asthenia—Dexamethasone—multiple sclerosis	5.45e-05	0.00031	CcSEcCtD
Dasatinib—ABCB1—central nervous system—multiple sclerosis	5.44e-05	0.000466	CbGeAlD
Dasatinib—Nervous system disorder—Methotrexate—multiple sclerosis	5.42e-05	0.000308	CcSEcCtD
Dasatinib—Thrombocytopenia—Methotrexate—multiple sclerosis	5.42e-05	0.000308	CcSEcCtD
Dasatinib—Gastrointestinal pain—Prednisone—multiple sclerosis	5.41e-05	0.000308	CcSEcCtD
Dasatinib—Nausea—Prednisolone—multiple sclerosis	5.41e-05	0.000307	CcSEcCtD
Dasatinib—Pruritus—Dexamethasone—multiple sclerosis	5.38e-05	0.000306	CcSEcCtD
Dasatinib—Pruritus—Betamethasone—multiple sclerosis	5.38e-05	0.000306	CcSEcCtD
Dasatinib—Skin disorder—Methotrexate—multiple sclerosis	5.37e-05	0.000305	CcSEcCtD
Dasatinib—Hyperhidrosis—Methotrexate—multiple sclerosis	5.35e-05	0.000304	CcSEcCtD
Dasatinib—Vomiting—Triamcinolone—multiple sclerosis	5.33e-05	0.000303	CcSEcCtD
Dasatinib—ABCB1—cerebellum—multiple sclerosis	5.32e-05	0.000455	CbGeAlD
Dasatinib—Vomiting—Methylprednisolone—multiple sclerosis	5.31e-05	0.000302	CcSEcCtD
Dasatinib—Rash—Triamcinolone—multiple sclerosis	5.28e-05	0.0003	CcSEcCtD
Dasatinib—Dermatitis—Triamcinolone—multiple sclerosis	5.28e-05	0.0003	CcSEcCtD
Dasatinib—Anorexia—Methotrexate—multiple sclerosis	5.27e-05	0.0003	CcSEcCtD
Dasatinib—Rash—Methylprednisolone—multiple sclerosis	5.27e-05	0.000299	CcSEcCtD
Dasatinib—Dermatitis—Methylprednisolone—multiple sclerosis	5.26e-05	0.000299	CcSEcCtD
Dasatinib—Urticaria—Prednisone—multiple sclerosis	5.26e-05	0.000299	CcSEcCtD
Dasatinib—Headache—Triamcinolone—multiple sclerosis	5.25e-05	0.000298	CcSEcCtD
Dasatinib—Headache—Methylprednisolone—multiple sclerosis	5.24e-05	0.000298	CcSEcCtD
Dasatinib—Abdominal pain—Prednisone—multiple sclerosis	5.23e-05	0.000297	CcSEcCtD
Dasatinib—Body temperature increased—Prednisone—multiple sclerosis	5.23e-05	0.000297	CcSEcCtD
Dasatinib—Diarrhoea—Betamethasone—multiple sclerosis	5.2e-05	0.000296	CcSEcCtD
Dasatinib—Diarrhoea—Dexamethasone—multiple sclerosis	5.2e-05	0.000296	CcSEcCtD
Dasatinib—Hypotension—Methotrexate—multiple sclerosis	5.17e-05	0.000294	CcSEcCtD
Dasatinib—Musculoskeletal discomfort—Methotrexate—multiple sclerosis	5.04e-05	0.000286	CcSEcCtD
Dasatinib—Dizziness—Dexamethasone—multiple sclerosis	5.03e-05	0.000286	CcSEcCtD
Dasatinib—Dizziness—Betamethasone—multiple sclerosis	5.03e-05	0.000286	CcSEcCtD
Dasatinib—Insomnia—Methotrexate—multiple sclerosis	5e-05	0.000284	CcSEcCtD
Dasatinib—Nausea—Triamcinolone—multiple sclerosis	4.98e-05	0.000283	CcSEcCtD
Dasatinib—Nausea—Methylprednisolone—multiple sclerosis	4.96e-05	0.000282	CcSEcCtD
Dasatinib—Dyspnoea—Methotrexate—multiple sclerosis	4.93e-05	0.00028	CcSEcCtD
Dasatinib—Somnolence—Methotrexate—multiple sclerosis	4.92e-05	0.000279	CcSEcCtD
Dasatinib—Hypersensitivity—Prednisone—multiple sclerosis	4.88e-05	0.000277	CcSEcCtD
Dasatinib—Dyspepsia—Methotrexate—multiple sclerosis	4.87e-05	0.000277	CcSEcCtD
Dasatinib—Vomiting—Betamethasone—multiple sclerosis	4.83e-05	0.000275	CcSEcCtD
Dasatinib—Vomiting—Dexamethasone—multiple sclerosis	4.83e-05	0.000275	CcSEcCtD
Dasatinib—Decreased appetite—Methotrexate—multiple sclerosis	4.81e-05	0.000273	CcSEcCtD
Dasatinib—Rash—Betamethasone—multiple sclerosis	4.79e-05	0.000272	CcSEcCtD
Dasatinib—Rash—Dexamethasone—multiple sclerosis	4.79e-05	0.000272	CcSEcCtD
Dasatinib—Dermatitis—Betamethasone—multiple sclerosis	4.79e-05	0.000272	CcSEcCtD
Dasatinib—Dermatitis—Dexamethasone—multiple sclerosis	4.79e-05	0.000272	CcSEcCtD
Dasatinib—Gastrointestinal disorder—Methotrexate—multiple sclerosis	4.78e-05	0.000271	CcSEcCtD
Dasatinib—Fatigue—Methotrexate—multiple sclerosis	4.77e-05	0.000271	CcSEcCtD
Dasatinib—Headache—Betamethasone—multiple sclerosis	4.76e-05	0.000271	CcSEcCtD
Dasatinib—Headache—Dexamethasone—multiple sclerosis	4.76e-05	0.000271	CcSEcCtD
Dasatinib—Asthenia—Prednisone—multiple sclerosis	4.75e-05	0.00027	CcSEcCtD
Dasatinib—Pain—Methotrexate—multiple sclerosis	4.73e-05	0.000269	CcSEcCtD
Dasatinib—Pruritus—Prednisone—multiple sclerosis	4.68e-05	0.000266	CcSEcCtD
Dasatinib—Feeling abnormal—Methotrexate—multiple sclerosis	4.56e-05	0.000259	CcSEcCtD
Dasatinib—Diarrhoea—Prednisone—multiple sclerosis	4.53e-05	0.000257	CcSEcCtD
Dasatinib—Gastrointestinal pain—Methotrexate—multiple sclerosis	4.52e-05	0.000257	CcSEcCtD
Dasatinib—Nausea—Dexamethasone—multiple sclerosis	4.51e-05	0.000257	CcSEcCtD
Dasatinib—Nausea—Betamethasone—multiple sclerosis	4.51e-05	0.000257	CcSEcCtD
Dasatinib—Urticaria—Methotrexate—multiple sclerosis	4.39e-05	0.00025	CcSEcCtD
Dasatinib—Dizziness—Prednisone—multiple sclerosis	4.38e-05	0.000249	CcSEcCtD
Dasatinib—Body temperature increased—Methotrexate—multiple sclerosis	4.37e-05	0.000248	CcSEcCtD
Dasatinib—Abdominal pain—Methotrexate—multiple sclerosis	4.37e-05	0.000248	CcSEcCtD
Dasatinib—ABCB1—brain—multiple sclerosis	4.32e-05	0.00037	CbGeAlD
Dasatinib—Vomiting—Prednisone—multiple sclerosis	4.21e-05	0.000239	CcSEcCtD
Dasatinib—Rash—Prednisone—multiple sclerosis	4.17e-05	0.000237	CcSEcCtD
Dasatinib—Dermatitis—Prednisone—multiple sclerosis	4.17e-05	0.000237	CcSEcCtD
Dasatinib—Headache—Prednisone—multiple sclerosis	4.15e-05	0.000236	CcSEcCtD
Dasatinib—Hypersensitivity—Methotrexate—multiple sclerosis	4.08e-05	0.000232	CcSEcCtD
Dasatinib—Asthenia—Methotrexate—multiple sclerosis	3.97e-05	0.000226	CcSEcCtD
Dasatinib—Nausea—Prednisone—multiple sclerosis	3.93e-05	0.000223	CcSEcCtD
Dasatinib—Pruritus—Methotrexate—multiple sclerosis	3.91e-05	0.000222	CcSEcCtD
Dasatinib—Diarrhoea—Methotrexate—multiple sclerosis	3.78e-05	0.000215	CcSEcCtD
Dasatinib—Dizziness—Methotrexate—multiple sclerosis	3.66e-05	0.000208	CcSEcCtD
Dasatinib—Vomiting—Methotrexate—multiple sclerosis	3.52e-05	0.0002	CcSEcCtD
Dasatinib—Rash—Methotrexate—multiple sclerosis	3.49e-05	0.000198	CcSEcCtD
Dasatinib—Dermatitis—Methotrexate—multiple sclerosis	3.48e-05	0.000198	CcSEcCtD
Dasatinib—Headache—Methotrexate—multiple sclerosis	3.47e-05	0.000197	CcSEcCtD
Dasatinib—Nausea—Methotrexate—multiple sclerosis	3.29e-05	0.000187	CcSEcCtD
Dasatinib—PDGFRA—Immune System—STAT3—multiple sclerosis	2.15e-06	9.63e-06	CbGpPWpGaD
Dasatinib—SRC—Disease—CD80—multiple sclerosis	2.15e-06	9.63e-06	CbGpPWpGaD
Dasatinib—SRC—Innate Immune System—MAPK1—multiple sclerosis	2.14e-06	9.62e-06	CbGpPWpGaD
Dasatinib—JAK2—Signaling Pathways—APOE—multiple sclerosis	2.14e-06	9.62e-06	CbGpPWpGaD
Dasatinib—MAPK14—Immune System—IL1B—multiple sclerosis	2.14e-06	9.6e-06	CbGpPWpGaD
Dasatinib—MAPK14—Immune System—IL2—multiple sclerosis	2.13e-06	9.57e-06	CbGpPWpGaD
Dasatinib—JAK2—Innate Immune System—IL6—multiple sclerosis	2.12e-06	9.53e-06	CbGpPWpGaD
Dasatinib—LCK—Signaling Pathways—SPP1—multiple sclerosis	2.12e-06	9.52e-06	CbGpPWpGaD
Dasatinib—RIPK2—Signaling Pathways—STAT3—multiple sclerosis	2.12e-06	9.52e-06	CbGpPWpGaD
Dasatinib—PDGFRB—Signaling Pathways—CD80—multiple sclerosis	2.11e-06	9.49e-06	CbGpPWpGaD
Dasatinib—JAK2—Immune System—IL1B—multiple sclerosis	2.11e-06	9.48e-06	CbGpPWpGaD
Dasatinib—JAK2—Disease—CD4—multiple sclerosis	2.11e-06	9.48e-06	CbGpPWpGaD
Dasatinib—CYP1A2—Metabolism of lipids and lipoproteins—APOE—multiple sclerosis	2.11e-06	9.46e-06	CbGpPWpGaD
Dasatinib—JAK2—Immune System—IL2—multiple sclerosis	2.1e-06	9.45e-06	CbGpPWpGaD
Dasatinib—ERBB3—Signaling Pathways—MMP9—multiple sclerosis	2.1e-06	9.44e-06	CbGpPWpGaD
Dasatinib—CYP3A4—Metabolism—RRM1—multiple sclerosis	2.1e-06	9.41e-06	CbGpPWpGaD
Dasatinib—KIT—Signaling Pathways—TYK2—multiple sclerosis	2.09e-06	9.39e-06	CbGpPWpGaD
Dasatinib—KIT—Disease—STAT3—multiple sclerosis	2.09e-06	9.39e-06	CbGpPWpGaD
Dasatinib—LCK—Immune System—IFNG—multiple sclerosis	2.07e-06	9.31e-06	CbGpPWpGaD
Dasatinib—LYN—Signaling Pathways—CD80—multiple sclerosis	2.07e-06	9.29e-06	CbGpPWpGaD
Dasatinib—LCK—Signaling Pathways—CCR5—multiple sclerosis	2.06e-06	9.26e-06	CbGpPWpGaD
Dasatinib—KIT—Immune System—MAPK1—multiple sclerosis	2.06e-06	9.25e-06	CbGpPWpGaD
Dasatinib—SRC—Signaling Pathways—CD86—multiple sclerosis	2.06e-06	9.24e-06	CbGpPWpGaD
Dasatinib—CYP1B1—Metabolism—POMC—multiple sclerosis	2.05e-06	9.21e-06	CbGpPWpGaD
Dasatinib—CSK—Signaling Pathways—IL6—multiple sclerosis	2.05e-06	9.19e-06	CbGpPWpGaD
Dasatinib—LCK—Disease—TYK2—multiple sclerosis	2.05e-06	9.18e-06	CbGpPWpGaD
Dasatinib—FYN—Signaling Pathways—CD80—multiple sclerosis	2.04e-06	9.15e-06	CbGpPWpGaD
Dasatinib—LCK—Signaling Pathways—IL2RA—multiple sclerosis	2.03e-06	9.12e-06	CbGpPWpGaD
Dasatinib—SRC—Signaling Pathways—CCL5—multiple sclerosis	2.03e-06	9.1e-06	CbGpPWpGaD
Dasatinib—ERBB3—Immune System—IL6—multiple sclerosis	2.02e-06	9.06e-06	CbGpPWpGaD
Dasatinib—PDGFRB—Signaling Pathways—POMC—multiple sclerosis	2.01e-06	9.02e-06	CbGpPWpGaD
Dasatinib—LCK—Immune System—CD4—multiple sclerosis	2e-06	8.99e-06	CbGpPWpGaD
Dasatinib—STAT5B—Signaling Pathways—IL6—multiple sclerosis	1.98e-06	8.9e-06	CbGpPWpGaD
Dasatinib—PDGFRA—Signaling Pathways—TYK2—multiple sclerosis	1.98e-06	8.89e-06	CbGpPWpGaD
Dasatinib—PDGFRA—Disease—STAT3—multiple sclerosis	1.98e-06	8.89e-06	CbGpPWpGaD
Dasatinib—RIPK2—Signaling Pathways—MYC—multiple sclerosis	1.97e-06	8.84e-06	CbGpPWpGaD
Dasatinib—LYN—Signaling Pathways—POMC—multiple sclerosis	1.97e-06	8.83e-06	CbGpPWpGaD
Dasatinib—ABCB1—Transmembrane transport of small molecules—ALB—multiple sclerosis	1.97e-06	8.82e-06	CbGpPWpGaD
Dasatinib—RIPK2—Signaling Pathways—TGFB1—multiple sclerosis	1.97e-06	8.82e-06	CbGpPWpGaD
Dasatinib—PDGFRB—Signaling Pathways—CCL2—multiple sclerosis	1.97e-06	8.82e-06	CbGpPWpGaD
Dasatinib—MAPK14—Signaling Pathways—CD80—multiple sclerosis	1.96e-06	8.81e-06	CbGpPWpGaD
Dasatinib—SRC—Immune System—TYK2—multiple sclerosis	1.96e-06	8.8e-06	CbGpPWpGaD
Dasatinib—ABCB1—Metabolism—BCHE—multiple sclerosis	1.95e-06	8.77e-06	CbGpPWpGaD
Dasatinib—PDGFRA—Immune System—MAPK1—multiple sclerosis	1.95e-06	8.75e-06	CbGpPWpGaD
Dasatinib—YES1—Signaling Pathways—IL2—multiple sclerosis	1.95e-06	8.75e-06	CbGpPWpGaD
Dasatinib—KIT—Disease—MYC—multiple sclerosis	1.94e-06	8.73e-06	CbGpPWpGaD
Dasatinib—KIT—Disease—TGFB1—multiple sclerosis	1.94e-06	8.71e-06	CbGpPWpGaD
Dasatinib—MAP2K5—Signaling Pathways—STAT3—multiple sclerosis	1.94e-06	8.7e-06	CbGpPWpGaD
Dasatinib—JAK2—Signaling Pathways—CD80—multiple sclerosis	1.94e-06	8.69e-06	CbGpPWpGaD
Dasatinib—FYN—Signaling Pathways—POMC—multiple sclerosis	1.94e-06	8.69e-06	CbGpPWpGaD
Dasatinib—PDGFRB—Immune System—STAT3—multiple sclerosis	1.93e-06	8.67e-06	CbGpPWpGaD
Dasatinib—RIPK2—Signaling Pathways—MAPK1—multiple sclerosis	1.93e-06	8.65e-06	CbGpPWpGaD
Dasatinib—LYN—Signaling Pathways—CCL2—multiple sclerosis	1.92e-06	8.64e-06	CbGpPWpGaD
Dasatinib—KIT—Disease—MAPK1—multiple sclerosis	1.9e-06	8.54e-06	CbGpPWpGaD
Dasatinib—FYN—Signaling Pathways—CCL2—multiple sclerosis	1.89e-06	8.5e-06	CbGpPWpGaD
Dasatinib—LYN—Immune System—STAT3—multiple sclerosis	1.89e-06	8.49e-06	CbGpPWpGaD
Dasatinib—ABL1—Immune System—STAT3—multiple sclerosis	1.88e-06	8.45e-06	CbGpPWpGaD
Dasatinib—SRC—Signaling Pathways—SPP1—multiple sclerosis	1.88e-06	8.42e-06	CbGpPWpGaD
Dasatinib—LCK—Signaling Pathways—APOE—multiple sclerosis	1.88e-06	8.42e-06	CbGpPWpGaD
Dasatinib—CYP1B1—Metabolism—ALB—multiple sclerosis	1.87e-06	8.4e-06	CbGpPWpGaD
Dasatinib—ERBB3—Signaling Pathways—STAT3—multiple sclerosis	1.87e-06	8.39e-06	CbGpPWpGaD
Dasatinib—ABCG2—Metabolism—POMC—multiple sclerosis	1.87e-06	8.38e-06	CbGpPWpGaD
Dasatinib—SRC—Developmental Biology—IL6—multiple sclerosis	1.86e-06	8.37e-06	CbGpPWpGaD
Dasatinib—ERBB3—Disease—IL6—multiple sclerosis	1.86e-06	8.37e-06	CbGpPWpGaD
Dasatinib—MAPK14—Signaling Pathways—POMC—multiple sclerosis	1.86e-06	8.37e-06	CbGpPWpGaD
Dasatinib—FYN—Immune System—STAT3—multiple sclerosis	1.86e-06	8.36e-06	CbGpPWpGaD
Dasatinib—LCK—Innate Immune System—IL6—multiple sclerosis	1.86e-06	8.35e-06	CbGpPWpGaD
Dasatinib—LCK—Immune System—IL1B—multiple sclerosis	1.85e-06	8.3e-06	CbGpPWpGaD
Dasatinib—LCK—Disease—CD4—multiple sclerosis	1.85e-06	8.3e-06	CbGpPWpGaD
Dasatinib—YES1—Signaling Pathways—MMP9—multiple sclerosis	1.85e-06	8.28e-06	CbGpPWpGaD
Dasatinib—LCK—Immune System—IL2—multiple sclerosis	1.84e-06	8.27e-06	CbGpPWpGaD
Dasatinib—PDGFRA—Disease—MYC—multiple sclerosis	1.84e-06	8.26e-06	CbGpPWpGaD
Dasatinib—JAK2—Signaling Pathways—POMC—multiple sclerosis	1.84e-06	8.26e-06	CbGpPWpGaD
Dasatinib—SRC—Immune System—IFNG—multiple sclerosis	1.84e-06	8.24e-06	CbGpPWpGaD
Dasatinib—PDGFRA—Disease—TGFB1—multiple sclerosis	1.84e-06	8.24e-06	CbGpPWpGaD
Dasatinib—SRC—Signaling Pathways—CCR5—multiple sclerosis	1.83e-06	8.2e-06	CbGpPWpGaD
Dasatinib—MAPK14—Signaling Pathways—CCL2—multiple sclerosis	1.82e-06	8.19e-06	CbGpPWpGaD
Dasatinib—SRC—Disease—TYK2—multiple sclerosis	1.81e-06	8.13e-06	CbGpPWpGaD
Dasatinib—CYP1A2—Metabolism of lipids and lipoproteins—POMC—multiple sclerosis	1.81e-06	8.12e-06	CbGpPWpGaD
Dasatinib—MAP2K5—Signaling Pathways—MYC—multiple sclerosis	1.8e-06	8.09e-06	CbGpPWpGaD
Dasatinib—JAK2—Signaling Pathways—CCL2—multiple sclerosis	1.8e-06	8.08e-06	CbGpPWpGaD
Dasatinib—PDGFRA—Disease—MAPK1—multiple sclerosis	1.8e-06	8.08e-06	CbGpPWpGaD
Dasatinib—SRC—Signaling Pathways—IL2RA—multiple sclerosis	1.8e-06	8.08e-06	CbGpPWpGaD
Dasatinib—MAP2K5—Signaling Pathways—TGFB1—multiple sclerosis	1.8e-06	8.07e-06	CbGpPWpGaD
Dasatinib—MAPK14—Immune System—STAT3—multiple sclerosis	1.79e-06	8.05e-06	CbGpPWpGaD
Dasatinib—PDGFRB—Signaling Pathways—TYK2—multiple sclerosis	1.78e-06	8.01e-06	CbGpPWpGaD
Dasatinib—PDGFRB—Disease—STAT3—multiple sclerosis	1.78e-06	8.01e-06	CbGpPWpGaD
Dasatinib—SRC—Immune System—CD4—multiple sclerosis	1.77e-06	7.96e-06	CbGpPWpGaD
Dasatinib—YES1—Immune System—IL6—multiple sclerosis	1.77e-06	7.96e-06	CbGpPWpGaD
Dasatinib—JAK2—Immune System—STAT3—multiple sclerosis	1.77e-06	7.95e-06	CbGpPWpGaD
Dasatinib—MAP2K5—Signaling Pathways—MAPK1—multiple sclerosis	1.76e-06	7.91e-06	CbGpPWpGaD
Dasatinib—JAK2—Signaling by GPCR—MAPK1—multiple sclerosis	1.76e-06	7.91e-06	CbGpPWpGaD
Dasatinib—PDGFRB—Immune System—MAPK1—multiple sclerosis	1.76e-06	7.89e-06	CbGpPWpGaD
Dasatinib—LYN—Signaling Pathways—TYK2—multiple sclerosis	1.75e-06	7.84e-06	CbGpPWpGaD
Dasatinib—KIT—Signaling Pathways—IL2—multiple sclerosis	1.74e-06	7.82e-06	CbGpPWpGaD
Dasatinib—ERBB3—Signaling Pathways—MYC—multiple sclerosis	1.74e-06	7.8e-06	CbGpPWpGaD
Dasatinib—ERBB3—Signaling Pathways—TGFB1—multiple sclerosis	1.73e-06	7.78e-06	CbGpPWpGaD
Dasatinib—FYN—Signaling Pathways—TYK2—multiple sclerosis	1.72e-06	7.72e-06	CbGpPWpGaD
Dasatinib—LYN—Immune System—MAPK1—multiple sclerosis	1.72e-06	7.72e-06	CbGpPWpGaD
Dasatinib—FYN—Disease—STAT3—multiple sclerosis	1.72e-06	7.72e-06	CbGpPWpGaD
Dasatinib—ABL1—Immune System—MAPK1—multiple sclerosis	1.71e-06	7.68e-06	CbGpPWpGaD
Dasatinib—ABCG2—Metabolism—ALB—multiple sclerosis	1.7e-06	7.64e-06	CbGpPWpGaD
Dasatinib—ERBB3—Signaling Pathways—MAPK1—multiple sclerosis	1.7e-06	7.63e-06	CbGpPWpGaD
Dasatinib—LCK—Signaling Pathways—CD80—multiple sclerosis	1.7e-06	7.61e-06	CbGpPWpGaD
Dasatinib—FYN—Immune System—MAPK1—multiple sclerosis	1.69e-06	7.6e-06	CbGpPWpGaD
Dasatinib—SRC—Signaling Pathways—APOE—multiple sclerosis	1.66e-06	7.46e-06	CbGpPWpGaD
Dasatinib—PDGFRB—Disease—MYC—multiple sclerosis	1.66e-06	7.44e-06	CbGpPWpGaD
Dasatinib—MAPK14—Gene Expression—MYC—multiple sclerosis	1.66e-06	7.44e-06	CbGpPWpGaD
Dasatinib—MAPK14—Signaling Pathways—TYK2—multiple sclerosis	1.66e-06	7.43e-06	CbGpPWpGaD
Dasatinib—PDGFRB—Disease—TGFB1—multiple sclerosis	1.65e-06	7.42e-06	CbGpPWpGaD
Dasatinib—CYP1A2—Metabolism of lipids and lipoproteins—ALB—multiple sclerosis	1.65e-06	7.41e-06	CbGpPWpGaD
Dasatinib—PDGFRA—Signaling Pathways—IL2—multiple sclerosis	1.65e-06	7.4e-06	CbGpPWpGaD
Dasatinib—KIT—Signaling Pathways—MMP9—multiple sclerosis	1.65e-06	7.4e-06	CbGpPWpGaD
Dasatinib—SRC—Innate Immune System—IL6—multiple sclerosis	1.65e-06	7.39e-06	CbGpPWpGaD
Dasatinib—YES1—Signaling Pathways—STAT3—multiple sclerosis	1.64e-06	7.36e-06	CbGpPWpGaD
Dasatinib—SRC—Immune System—IL1B—multiple sclerosis	1.64e-06	7.35e-06	CbGpPWpGaD
Dasatinib—SRC—Disease—CD4—multiple sclerosis	1.64e-06	7.35e-06	CbGpPWpGaD
Dasatinib—JAK2—Signaling Pathways—TYK2—multiple sclerosis	1.64e-06	7.34e-06	CbGpPWpGaD
Dasatinib—JAK2—Disease—STAT3—multiple sclerosis	1.64e-06	7.34e-06	CbGpPWpGaD
Dasatinib—SRC—Immune System—IL2—multiple sclerosis	1.63e-06	7.32e-06	CbGpPWpGaD
Dasatinib—MAPK14—Immune System—MAPK1—multiple sclerosis	1.63e-06	7.32e-06	CbGpPWpGaD
Dasatinib—PDGFRB—Disease—MAPK1—multiple sclerosis	1.62e-06	7.28e-06	CbGpPWpGaD
Dasatinib—LCK—Signaling Pathways—POMC—multiple sclerosis	1.61e-06	7.23e-06	CbGpPWpGaD
Dasatinib—JAK2—Immune System—MAPK1—multiple sclerosis	1.61e-06	7.23e-06	CbGpPWpGaD
Dasatinib—FYN—Disease—MYC—multiple sclerosis	1.6e-06	7.17e-06	CbGpPWpGaD
Dasatinib—FYN—Disease—TGFB1—multiple sclerosis	1.59e-06	7.16e-06	CbGpPWpGaD
Dasatinib—KIT—Immune System—IL6—multiple sclerosis	1.58e-06	7.11e-06	CbGpPWpGaD
Dasatinib—LCK—Signaling Pathways—CCL2—multiple sclerosis	1.58e-06	7.08e-06	CbGpPWpGaD
Dasatinib—FYN—Disease—MAPK1—multiple sclerosis	1.56e-06	7.02e-06	CbGpPWpGaD
Dasatinib—PDGFRA—Signaling Pathways—MMP9—multiple sclerosis	1.56e-06	7e-06	CbGpPWpGaD
Dasatinib—CYP1A2—Metabolism—BCHE—multiple sclerosis	1.56e-06	7e-06	CbGpPWpGaD
Dasatinib—CYP3A5—Metabolism—APOE—multiple sclerosis	1.56e-06	6.99e-06	CbGpPWpGaD
Dasatinib—LCK—Immune System—STAT3—multiple sclerosis	1.55e-06	6.96e-06	CbGpPWpGaD
Dasatinib—YES1—Signaling Pathways—MYC—multiple sclerosis	1.52e-06	6.84e-06	CbGpPWpGaD
Dasatinib—YES1—Signaling Pathways—TGFB1—multiple sclerosis	1.52e-06	6.83e-06	CbGpPWpGaD
Dasatinib—JAK2—Disease—MYC—multiple sclerosis	1.52e-06	6.82e-06	CbGpPWpGaD
Dasatinib—JAK2—Disease—TGFB1—multiple sclerosis	1.52e-06	6.8e-06	CbGpPWpGaD
Dasatinib—SRC—Signaling Pathways—CD80—multiple sclerosis	1.5e-06	6.74e-06	CbGpPWpGaD
Dasatinib—PDGFRA—Immune System—IL6—multiple sclerosis	1.5e-06	6.73e-06	CbGpPWpGaD
Dasatinib—YES1—Signaling Pathways—MAPK1—multiple sclerosis	1.49e-06	6.69e-06	CbGpPWpGaD
Dasatinib—JAK2—Disease—MAPK1—multiple sclerosis	1.49e-06	6.67e-06	CbGpPWpGaD
Dasatinib—PDGFRB—Signaling Pathways—IL2—multiple sclerosis	1.49e-06	6.66e-06	CbGpPWpGaD
Dasatinib—RIPK2—Signaling Pathways—IL6—multiple sclerosis	1.48e-06	6.65e-06	CbGpPWpGaD
Dasatinib—CYP1A1—Metabolism—APOE—multiple sclerosis	1.47e-06	6.6e-06	CbGpPWpGaD
Dasatinib—KIT—Signaling Pathways—STAT3—multiple sclerosis	1.47e-06	6.58e-06	CbGpPWpGaD
Dasatinib—KIT—Disease—IL6—multiple sclerosis	1.46e-06	6.56e-06	CbGpPWpGaD
Dasatinib—LYN—Signaling Pathways—IL2—multiple sclerosis	1.45e-06	6.53e-06	CbGpPWpGaD
Dasatinib—LCK—Signaling Pathways—TYK2—multiple sclerosis	1.43e-06	6.43e-06	CbGpPWpGaD
Dasatinib—LCK—Disease—STAT3—multiple sclerosis	1.43e-06	6.43e-06	CbGpPWpGaD
Dasatinib—FYN—Signaling Pathways—IL2—multiple sclerosis	1.43e-06	6.42e-06	CbGpPWpGaD
Dasatinib—SRC—Signaling Pathways—POMC—multiple sclerosis	1.43e-06	6.4e-06	CbGpPWpGaD
Dasatinib—LCK—Immune System—MAPK1—multiple sclerosis	1.41e-06	6.33e-06	CbGpPWpGaD
Dasatinib—PDGFRB—Signaling Pathways—MMP9—multiple sclerosis	1.41e-06	6.31e-06	CbGpPWpGaD
Dasatinib—SRC—Signaling Pathways—CCL2—multiple sclerosis	1.4e-06	6.27e-06	CbGpPWpGaD
Dasatinib—PDGFRA—Signaling Pathways—STAT3—multiple sclerosis	1.39e-06	6.23e-06	CbGpPWpGaD
Dasatinib—PDGFRA—Disease—IL6—multiple sclerosis	1.38e-06	6.21e-06	CbGpPWpGaD
Dasatinib—MAPK14—Signaling Pathways—IL2—multiple sclerosis	1.38e-06	6.19e-06	CbGpPWpGaD
Dasatinib—LYN—Signaling Pathways—MMP9—multiple sclerosis	1.38e-06	6.18e-06	CbGpPWpGaD
Dasatinib—SRC—Immune System—STAT3—multiple sclerosis	1.37e-06	6.16e-06	CbGpPWpGaD
Dasatinib—KIT—Signaling Pathways—MYC—multiple sclerosis	1.36e-06	6.11e-06	CbGpPWpGaD
Dasatinib—JAK2—Signaling Pathways—IL2—multiple sclerosis	1.36e-06	6.11e-06	CbGpPWpGaD
Dasatinib—KIT—Signaling Pathways—TGFB1—multiple sclerosis	1.36e-06	6.1e-06	CbGpPWpGaD
Dasatinib—FYN—Signaling Pathways—MMP9—multiple sclerosis	1.35e-06	6.08e-06	CbGpPWpGaD
Dasatinib—MAP2K5—Signaling Pathways—IL6—multiple sclerosis	1.35e-06	6.08e-06	CbGpPWpGaD
Dasatinib—JAK2—Signaling by GPCR—IL6—multiple sclerosis	1.35e-06	6.08e-06	CbGpPWpGaD
Dasatinib—PDGFRB—Immune System—IL6—multiple sclerosis	1.35e-06	6.06e-06	CbGpPWpGaD
Dasatinib—CYP3A5—Metabolism—POMC—multiple sclerosis	1.34e-06	6.01e-06	CbGpPWpGaD
Dasatinib—KIT—Signaling Pathways—MAPK1—multiple sclerosis	1.33e-06	5.98e-06	CbGpPWpGaD
Dasatinib—LCK—Disease—MYC—multiple sclerosis	1.33e-06	5.97e-06	CbGpPWpGaD
Dasatinib—LCK—Disease—TGFB1—multiple sclerosis	1.33e-06	5.96e-06	CbGpPWpGaD
Dasatinib—LYN—Immune System—IL6—multiple sclerosis	1.32e-06	5.93e-06	CbGpPWpGaD
Dasatinib—ABL1—Immune System—IL6—multiple sclerosis	1.32e-06	5.9e-06	CbGpPWpGaD
Dasatinib—ERBB3—Signaling Pathways—IL6—multiple sclerosis	1.31e-06	5.86e-06	CbGpPWpGaD
Dasatinib—MAPK14—Signaling Pathways—MMP9—multiple sclerosis	1.3e-06	5.85e-06	CbGpPWpGaD
Dasatinib—LCK—Disease—MAPK1—multiple sclerosis	1.3e-06	5.84e-06	CbGpPWpGaD
Dasatinib—FYN—Immune System—IL6—multiple sclerosis	1.3e-06	5.84e-06	CbGpPWpGaD
Dasatinib—PDGFRA—Signaling Pathways—MYC—multiple sclerosis	1.29e-06	5.78e-06	CbGpPWpGaD
Dasatinib—JAK2—Signaling Pathways—MMP9—multiple sclerosis	1.29e-06	5.78e-06	CbGpPWpGaD
Dasatinib—PDGFRA—Signaling Pathways—TGFB1—multiple sclerosis	1.29e-06	5.77e-06	CbGpPWpGaD
Dasatinib—SRC—Signaling Pathways—TYK2—multiple sclerosis	1.27e-06	5.69e-06	CbGpPWpGaD
Dasatinib—SRC—Disease—STAT3—multiple sclerosis	1.27e-06	5.69e-06	CbGpPWpGaD
Dasatinib—CYP1A1—Metabolism—POMC—multiple sclerosis	1.26e-06	5.67e-06	CbGpPWpGaD
Dasatinib—PDGFRA—Signaling Pathways—MAPK1—multiple sclerosis	1.26e-06	5.66e-06	CbGpPWpGaD
Dasatinib—MAPK14—Immune System—IL6—multiple sclerosis	1.25e-06	5.62e-06	CbGpPWpGaD
Dasatinib—PDGFRB—Signaling Pathways—STAT3—multiple sclerosis	1.25e-06	5.61e-06	CbGpPWpGaD
Dasatinib—SRC—Immune System—MAPK1—multiple sclerosis	1.25e-06	5.6e-06	CbGpPWpGaD
Dasatinib—PDGFRB—Disease—IL6—multiple sclerosis	1.25e-06	5.59e-06	CbGpPWpGaD
Dasatinib—JAK2—Immune System—IL6—multiple sclerosis	1.24e-06	5.55e-06	CbGpPWpGaD
Dasatinib—LYN—Signaling Pathways—STAT3—multiple sclerosis	1.22e-06	5.49e-06	CbGpPWpGaD
Dasatinib—CYP3A5—Metabolism—ALB—multiple sclerosis	1.22e-06	5.48e-06	CbGpPWpGaD
Dasatinib—FYN—Signaling Pathways—STAT3—multiple sclerosis	1.2e-06	5.41e-06	CbGpPWpGaD
Dasatinib—CYP3A4—Metabolism—BCHE—multiple sclerosis	1.2e-06	5.4e-06	CbGpPWpGaD
Dasatinib—FYN—Disease—IL6—multiple sclerosis	1.2e-06	5.39e-06	CbGpPWpGaD
Dasatinib—LCK—Signaling Pathways—IL2—multiple sclerosis	1.19e-06	5.35e-06	CbGpPWpGaD
Dasatinib—SRC—Disease—MYC—multiple sclerosis	1.18e-06	5.29e-06	CbGpPWpGaD
Dasatinib—ABCB1—Metabolism—APOE—multiple sclerosis	1.18e-06	5.28e-06	CbGpPWpGaD
Dasatinib—SRC—Disease—TGFB1—multiple sclerosis	1.18e-06	5.27e-06	CbGpPWpGaD
Dasatinib—PDGFRB—Signaling Pathways—MYC—multiple sclerosis	1.16e-06	5.21e-06	CbGpPWpGaD
Dasatinib—MAPK14—Signaling Pathways—STAT3—multiple sclerosis	1.16e-06	5.21e-06	CbGpPWpGaD
Dasatinib—PDGFRB—Signaling Pathways—TGFB1—multiple sclerosis	1.16e-06	5.2e-06	CbGpPWpGaD
Dasatinib—CYP1A1—Metabolism—ALB—multiple sclerosis	1.15e-06	5.17e-06	CbGpPWpGaD
Dasatinib—SRC—Disease—MAPK1—multiple sclerosis	1.15e-06	5.17e-06	CbGpPWpGaD
Dasatinib—YES1—Signaling Pathways—IL6—multiple sclerosis	1.15e-06	5.14e-06	CbGpPWpGaD
Dasatinib—JAK2—Signaling Pathways—STAT3—multiple sclerosis	1.15e-06	5.14e-06	CbGpPWpGaD
Dasatinib—JAK2—Disease—IL6—multiple sclerosis	1.14e-06	5.13e-06	CbGpPWpGaD
Dasatinib—LYN—Signaling Pathways—MYC—multiple sclerosis	1.14e-06	5.1e-06	CbGpPWpGaD
Dasatinib—PDGFRB—Signaling Pathways—MAPK1—multiple sclerosis	1.14e-06	5.1e-06	CbGpPWpGaD
Dasatinib—LYN—Signaling Pathways—TGFB1—multiple sclerosis	1.13e-06	5.09e-06	CbGpPWpGaD
Dasatinib—LCK—Signaling Pathways—MMP9—multiple sclerosis	1.13e-06	5.06e-06	CbGpPWpGaD
Dasatinib—FYN—Signaling Pathways—MYC—multiple sclerosis	1.12e-06	5.02e-06	CbGpPWpGaD
Dasatinib—FYN—Signaling Pathways—TGFB1—multiple sclerosis	1.12e-06	5.01e-06	CbGpPWpGaD
Dasatinib—LYN—Signaling Pathways—MAPK1—multiple sclerosis	1.11e-06	4.99e-06	CbGpPWpGaD
Dasatinib—FYN—Signaling Pathways—MAPK1—multiple sclerosis	1.1e-06	4.91e-06	CbGpPWpGaD
Dasatinib—LCK—Immune System—IL6—multiple sclerosis	1.08e-06	4.86e-06	CbGpPWpGaD
Dasatinib—MAPK14—Signaling Pathways—MYC—multiple sclerosis	1.08e-06	4.84e-06	CbGpPWpGaD
Dasatinib—MAPK14—Signaling Pathways—TGFB1—multiple sclerosis	1.08e-06	4.83e-06	CbGpPWpGaD
Dasatinib—JAK2—Signaling Pathways—MYC—multiple sclerosis	1.06e-06	4.77e-06	CbGpPWpGaD
Dasatinib—JAK2—Signaling Pathways—TGFB1—multiple sclerosis	1.06e-06	4.76e-06	CbGpPWpGaD
Dasatinib—SRC—Signaling Pathways—IL2—multiple sclerosis	1.06e-06	4.74e-06	CbGpPWpGaD
Dasatinib—MAPK14—Signaling Pathways—MAPK1—multiple sclerosis	1.05e-06	4.73e-06	CbGpPWpGaD
Dasatinib—JAK2—Signaling Pathways—MAPK1—multiple sclerosis	1.04e-06	4.67e-06	CbGpPWpGaD
Dasatinib—KIT—Signaling Pathways—IL6—multiple sclerosis	1.02e-06	4.59e-06	CbGpPWpGaD
Dasatinib—ABCB1—Metabolism—POMC—multiple sclerosis	1.01e-06	4.53e-06	CbGpPWpGaD
Dasatinib—LCK—Signaling Pathways—STAT3—multiple sclerosis	1e-06	4.5e-06	CbGpPWpGaD
Dasatinib—LCK—Disease—IL6—multiple sclerosis	1e-06	4.49e-06	CbGpPWpGaD
Dasatinib—SRC—Signaling Pathways—MMP9—multiple sclerosis	9.99e-07	4.48e-06	CbGpPWpGaD
Dasatinib—PDGFRA—Signaling Pathways—IL6—multiple sclerosis	9.69e-07	4.35e-06	CbGpPWpGaD
Dasatinib—SRC—Immune System—IL6—multiple sclerosis	9.59e-07	4.3e-06	CbGpPWpGaD
Dasatinib—CYP1A2—Metabolism—APOE—multiple sclerosis	9.38e-07	4.21e-06	CbGpPWpGaD
Dasatinib—LCK—Signaling Pathways—MYC—multiple sclerosis	9.32e-07	4.18e-06	CbGpPWpGaD
Dasatinib—LCK—Signaling Pathways—TGFB1—multiple sclerosis	9.3e-07	4.17e-06	CbGpPWpGaD
Dasatinib—ABCB1—Metabolism—ALB—multiple sclerosis	9.21e-07	4.13e-06	CbGpPWpGaD
Dasatinib—LCK—Signaling Pathways—MAPK1—multiple sclerosis	9.12e-07	4.09e-06	CbGpPWpGaD
Dasatinib—SRC—Signaling Pathways—STAT3—multiple sclerosis	8.88e-07	3.98e-06	CbGpPWpGaD
Dasatinib—SRC—Disease—IL6—multiple sclerosis	8.86e-07	3.97e-06	CbGpPWpGaD
Dasatinib—PDGFRB—Signaling Pathways—IL6—multiple sclerosis	8.73e-07	3.92e-06	CbGpPWpGaD
Dasatinib—LYN—Signaling Pathways—IL6—multiple sclerosis	8.55e-07	3.84e-06	CbGpPWpGaD
Dasatinib—FYN—Signaling Pathways—IL6—multiple sclerosis	8.41e-07	3.78e-06	CbGpPWpGaD
Dasatinib—SRC—Signaling Pathways—MYC—multiple sclerosis	8.25e-07	3.7e-06	CbGpPWpGaD
Dasatinib—SRC—Signaling Pathways—TGFB1—multiple sclerosis	8.23e-07	3.69e-06	CbGpPWpGaD
Dasatinib—MAPK14—Signaling Pathways—IL6—multiple sclerosis	8.1e-07	3.64e-06	CbGpPWpGaD
Dasatinib—SRC—Signaling Pathways—MAPK1—multiple sclerosis	8.07e-07	3.62e-06	CbGpPWpGaD
Dasatinib—CYP1A2—Metabolism—POMC—multiple sclerosis	8.06e-07	3.62e-06	CbGpPWpGaD
Dasatinib—JAK2—Signaling Pathways—IL6—multiple sclerosis	8e-07	3.59e-06	CbGpPWpGaD
Dasatinib—CYP1A2—Metabolism—ALB—multiple sclerosis	7.35e-07	3.3e-06	CbGpPWpGaD
Dasatinib—CYP3A4—Metabolism—APOE—multiple sclerosis	7.24e-07	3.25e-06	CbGpPWpGaD
Dasatinib—LCK—Signaling Pathways—IL6—multiple sclerosis	7.01e-07	3.14e-06	CbGpPWpGaD
Dasatinib—CYP3A4—Metabolism—POMC—multiple sclerosis	6.22e-07	2.79e-06	CbGpPWpGaD
Dasatinib—SRC—Signaling Pathways—IL6—multiple sclerosis	6.2e-07	2.78e-06	CbGpPWpGaD
Dasatinib—CYP3A4—Metabolism—ALB—multiple sclerosis	5.67e-07	2.55e-06	CbGpPWpGaD
